Barriers to hepatitis C treatment in the era of direct acting antiviral agents

BACKGROUND: Direct-acting antivirals (DAA) are safe, effective treatment of hepatitis C virus (HCV). Suboptimal linkage to specialists and access to DAAs are the leading barriers to treatment; however, data are limited. AIM: Determine predictors of follow-up, receipt of DAAs, and reasons for the lac...

Full description

Saved in:
Bibliographic Details
Published in:Aliment Pharmacol Ther
Main Authors: Lin, Michael, Kramer, Jennifer, White, Donna, Cao, Yumei, Tavakoli-Tabasi, Shahriar, Madu, Stella, Smith, Donna, Asch, Steven M., El-Serag, Hashem B., Kanwal, Fasiha
Format: Artigo
Language:Inglês
Published: 2017
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5800315/
https://ncbi.nlm.nih.gov/pubmed/28949020
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/apt.14328
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items